The ethics of using biased artificial intelligence programs in the clinic

Sood, Aditya; Sangari, Ayush; Chen, Jared Y.; Stoff, Benjamin K.

doi:10.1016/j.jaad.2021.11.031

Cited by 5 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 50 - 53 Researchers should be aware of existing bias in certain databases and trained models as well as steps that can be undertaken to limit them. 50 , 51 , 54 , 55 …”

Section: Discussionmentioning

confidence: 99%

The State of Artificial Intelligence in Skin Cancer Publications

Joly-Chevrier,

Nguyen,

Liang

et al. 2024

J Cutan Med Surg

View full text Add to dashboard Cite

Background: Artificial intelligence (AI) in skin cancer is a promising research field to assist physicians and to provide support to patients remotely. Physicians’ awareness to new developments in AI research is important to define the best practices and scope of integrating AI-enabled technologies within a clinical setting. Objectives: To analyze the characteristics and trends of AI skin cancer publications from dermatology journals. Methods: AI skin cancer publications were retrieved in June 2022 from the Web of Science. Publications were screened by title, abstract, and keywords to assess eligibility. Publications were fully reviewed. Publications were divided between nonmelanoma skin cancer (NMSC), melanoma, and skin cancer studies. The primary measured outcome was the number of citations. The secondary measured outcomes were articles’ general characteristics and features related to AI. Results: A total of 168 articles were included: 25 on NMSC, 77 on melanoma, and 66 on skin cancer. The most common types of skin cancers were melanoma (134, 79.8%), basal cell carcinoma (61, 36.3%), and squamous cell carcinoma (45, 26.9%). All articles were published between 2000 and 2022, with 49 (29.2%) of them being published in 2021. Original studies that developed or assessed an algorithm predominantly used supervised learning (66, 97.0%) and deep neural networks (42, 67.7%). The most used imaging modalities were standard dermoscopy (76, 45.2%) and clinical images (39, 23.2%). Conclusions: Most publications focused on developing or assessing screening technologies with mainly deep neural network algorithms. This indicates the eminent need for dermatologists to label or annotate images used by novel AI systems.

show abstract

“… 50 - 53 Researchers should be aware of existing bias in certain databases and trained models as well as steps that can be undertaken to limit them. 50 , 51 , 54 , 55 …”

Section: Discussionmentioning

confidence: 99%

The State of Artificial Intelligence in Skin Cancer Publications

Joly-Chevrier,

Nguyen,

Liang

et al. 2024

J Cutan Med Surg

View full text Add to dashboard Cite

show abstract

“…Researchers must advocate for the development and utilization of more comprehensive, diverse, and inclusive datasets that accurately represent marginalized communities and various socioeconomic backgrounds ( 15 , 22 , 25 – 28 ). There must be collaborations among healthcare institutions, community organizations, and AI developers to ensure the incorporation of diverse perspectives ( 8 , 22 , 29 , 30 ).…”

Section: Recommendations For Leveraging Ai To Address Health Disparitiesmentioning

confidence: 99%